 |
|
|
|
 |
|
|
| Article 1 to 8 out of 8 concerning University of Alberta
|
-
Unlikely genetic suspect implicated in common brain defect
(11 Aug 2009)
A genetic search that wound its way from patients to mouse models and back to patients has uncovered an unlikely gene critically involved in a common birth defect which causes mental retardation, motor delays and sometimes autism, providing a new ...
-
Lab on a chip developed at University of Alberta for cheap, portable medical tests
(31 Jan 2008)
University of Alberta researchers in Edmonton, Canada, have developed a portable unit for genetic testing about the size of a shoebox, which has the same capability as a lab full of expensive equipment. The device - along with other, even smaller ...
-
Alberta researchers 1st to complete the human metabolome
(26 Jan 2007)
Researchers at the University of Alberta, Canada, have announced the completion of the first draft of the human metabolome, the chemical equivalent of the human genome. The metabolome is the complete complement of all small molecule chemicals ...
-
BioMS Medical receives additional patent for multiple sclerosis drug MBP8298 in the United States
(06 Nov 2006)
BioMS Medical Corp announced that the University of Alberta has received additional patents for the Company's synthetic peptide therapeutic, MBP8298, for the treatment of multiple sclerosis (MS). BioMS Medical licenses these patents on an exclusive ...
-
Geron announces issuance of US patent for production of insulin secreting cells from human embryonic stem cells
(28 Apr 2006)
Geron Corporation announced that it has been granted U.S. Patent No. 7,033,831, covering the production of insulin secreting cells from human embryonic stem cells (hESCs). The new patent covers methods developed by Geron scientists working towards ...
-
Alberta and Varian, Inc. collaborate on disease diagnosis research
(01 Feb 2006)
Government funds second phase of the Magnetic Resonance Diagnostics Centre
Alberta's Magnetic Resonance Diagnostics Centre at the University of Alberta is getting a boost for continuing collaborative disease diagnosis research using the emerging science of metabolomics. The Alberta government and Varian, Inc. are extending ...
-
Geron announces improved production method for human embryonic stem cell-derived islet cells
(31 Jan 2006)
Geron Corporation announced the presentation of a new production protocol to differentiate islet cells from human embryonic stem cells (hESCs) for the treatment of diabetes. Dr. Anish Majumdar, Geron's Senior Director of Cell Therapy Research, ...
-
BioMS Medical receives 38 additional patents for multiple sclerosis drug MBP8298
(09 Dec 2005)
BioMS Medical Corp, a developer in the treatment of multiple sclerosis (MS), announced that the University of Alberta has received thirty-eight additional patents for the Company's synthetic peptide therapeutic, MBP8298, for the treatment of ...
|
|
|
|
|
Top